Miracalus Pharma Pvt Limited
|
|
- Melinda Blake
- 5 years ago
- Views:
Transcription
1 Dealers in Vaccines, TPN, Blood products and All Anti-Cancer Drugs Miracalus Pharma Pvt Limited ANTI CANCER - Injections ING CISPLATIN 10MG CISTEEN 1 VIAL ING CISPLATIN 50MG CISTEEN 1 VIAL INJ 5 FLURO URACIL 250 MG NAPROCIL 5 AMP INJ 5 FLURO URACIL 500 MG NAPROCIL 5 AMP INJ BLEOMYCIN 15 MG NAPROBLEO 1 VIAL INJ CARBOPLATIN 150 MG NAPROPLAT 1 VIAL INJ CARBOPLATIN 450 MG NAPROPLAT 1 VIAL INJ CYCLOPHOSPHAMIDE 200MG CYCRAME 200 mg 1 VIAL INJ CYCLOPHOSPHOMIDE 1 GM CYCRAME 1 gm 1 VIAL INJ CYCLOPHOSPHOMIDE 500 MG CYCRAME 500 mg 1 VIAL INJ CYTARABINE 100 MG CANCYST 1 VIAL INJ CYTARABINE 1GM CANCYST 1 VIAL INJ CYTARABINE 500 MG CANCYST 1 VIAL INJ DACARBAZINE 100 MG ARZI 1 VIAL INJ DACARBAZINE 200 MG ARZI 1 VIAL INJ DACARBAZINE 500 MG ARZI 1 VIAL INJ DAUNORUBICIN 20 MG DAUNOCIN 1 VIAL INJ DOCETAXEL 120 MG TACEDO 1 VIAL INJ DOCETAXEL 20 MG TACEDO 1 VIAL INJ DOCETAXEL 80 MG TACEDO 1 VIAL INJ DOXORUBICIN 10 MG NAPRODOX 1 VIAL INJ DOXORUBICIN 50 MG NAPRODOX 1 VIAL INJ EPIRUBICIN 10 MG 4-EPEEDO 1 VIAL INJ EPIRUBICIN 50 MG 4-EPEEDO 1 VIAL INJ ETOPOSIDE 100 MG NZYTOP 1 VIAL INJ GEMCITABINE 1GM ABINGEM 1 gm 1VIAL INJ GEMCITABINE 200 MG ABINGEM 200 mg 1VIAL INJ IFOSPHAMIDE WITH MESNA 1 GM ISOXAN WITH UROMES 1VIAL INJ IFOSPHAMIDE WITH MESNA 2 GM ISOXAN WITH UROMES 1VIAL INJ IRINOTICAN 100 MG TORSIRIN 1VIAL INJ IRINOTICAN 40 MG TORSIRIN 1VIAL INJ L-ASPARGINASE IU L-ASPASE 1VIAL INJ L-ASPARGINASE 5000 IU L-ASPASE 1VIAL INJ LEUCOVIRON CALCIUM 15 MG CAFONATE 10 AMP INJ LEUCOVIRON CALCIUM 50 MG CAFONATE 1 VIAL
2 INJ METHOTREXATE 15 MG PF ALTREX 1 VIAL INJ METHOTREXATE 50 MG ALTREX 1 VIAL INJ METHOTREXATE 500 MG ALTREX 1 VIAL INJ MITOMYCIN 10MG VESIMYCIN 10 mg 1 VIAL INJ MITOMYCIN 2MG VESIMYCIN 2 mg 1 VIAL INJ MITOZANTRONE 20 MG MITOZAN 1 VIAL INJ OXALIPLATIN 100 MG ZILDOX 1 VIAL INJ OXALIPLATIN 50 MG ZILDOX 1 VIAL INJ PACLITAXEL 100 MG NAPRO-TAX 1 VIAL INJ PACLITAXEL 260 MG NAPRO-TAX 1 VIAL INJ PACLITAXEL 30 MG NAPRO-TAX 1 VIAL INJ VINCRISTIN SULPHATE 1 MG VINROSA 1 VIAL INJ VINORELBINE 10 MG RELBOVIN 1 VIAL INJ VINORELBINE 50 MG RELBOVIN 1 VIAL INJ ZOLENDRONIC ACID 4 MG ZIFONATE 1 VIAL INJ.AMIFOSTINE 500 MG NAPROFOS 1 VIAL ANTI CANCER - Tablets TAB ANASTRAZOLE 1 MG PMBC 2X 14 T TAB AZATHIPRINE 50 MG ZIOPRIN 10X10 TAB BICALUTIMIDE 50 MG MACABI 10X10 TAB BUSULFAN 2MG TABUCEF 10X10 TAB CAPECITABINE 500MG NAPROCAP 1X10 TAB IMATINIB 100 MG MESYLONIB 1X10 TAB IMATINIB 400 MG MESYLONIB 1X10 TAB LETROZOLE 2.5 MG LETORIPE 3X10 TAB MERCAPTOPURINE 50 MG PURINETONE 10X10 TAB METHOTREXATE 2.5 MG ALTREX 10X10 TAB TAMOXIFEN 10 MG XIFEN 10X10 TAB TAMOXIFEN 20 MG XIFEN 10X10 TAB THALIDOMIDE 100 MG TOLIMID 2X5 TAB THALIDOMIDE 50 MG TOLIMID 2X5 TAB THIOGUANINE 40 MG 6-TG 10X10 ANTI CANCER - Capsules CAP HYDROXY UREA 500 MG READROX 5X10 CAP LOMUSTINE 40 MG MOOSTIN 1X6 CAP PROCARBAZINE 50 MG ZINOCARB 5X10 CAP TEMOZOLAMIDE 100 MG EMZOLAM 1X5 CAP TEMOZOLAMIDE 20 MG EMZOLAM 1X5 CAP TEMOZOLAMIDE 250 MG EMZOLAM 1X5
3 Gold Shield Health Care Private Limited ANTI CANCER Cisgold Inj Cisplatin 10 mg 1 VIAL Cisgold 50 mg Inj Cisplatin 50 mg 1 VIAL Carbogold 150 mg Inj Carboplatin 150 mg 1 VIAL Carbogold 450 mg Inj Carboplatin 450 mg 1 VIAL Docegold 120 mg Inj Docetaxel 120 mg 1 VIAL Docegold 20 mg Inj Docetaxel 20 mg 1 VIAL Docegold 80 mg Inj Docetaxel 80 mg 1 VIAL Doxogold 10 mg Inj Doxorubicin 10 mg 1 VIAL Doxogold 50 mg Inj Doxorubicin 50 mg 1 VIAL Gemgold 1gm Inj Gemcitabine 1 gm 1 VIAL Gemgold 200 mg Inj Gemcitabine 200 mg 1 VIAL Zolegold Inj Ziolendronic Acid 4 mg 1 VIAL Oxaligold 100 mg Inj Oxaliplatin 100 mg 1 VIAL Oxaligold 50 mg Inj Oxaliplatin 50 mg 1 VIAL Pacligold 100 mg Inj Paclitaxel 100 mg 1 VIAL Pacligold 250 mg Inj Paclitaxel 250 mg 1 VIAL Pacligold 30 mg Inj Paclitaxel 30 mg 1 VIAL Tezogold 100 mg Cap Temozolamide 100 mg 1x5 Cap Tezogold 20 mg Cap Temozolamide 20 mg 1x5 Cap Tezogold 250 mg Cap Temozolamide 250 mg 1x5 Cap Goldtinib 100 mg Tab Imatinib 100 mg 1x10 Tab Goldtinib 400 mg Tab Imatinib 400 mg 1x10 Tab Geftigold 250 mg Tab Tab Gefitinib 250 mg 1x10 Tab Letrogold 2.5 mg Tab Tab Letrozole 2.5 mg 1x10 Tab Anastragold 1 mg Tab Tab Anastrazole 1mg 1x10 Tab Curocure Cap Curcumin with Piperine Cap 30 Cap Lycocure Cap Lycopene 10 mg Cao 30 Cap Goldcetabine 500 mg Capecitabine 500 mg 1x10 Cap
4 United Biotech Private Limited Cefoprim 750 mg Onj Cefuroxime Sodium 750 mg Inj 1 Vial Cefoprim 1.5gm Inj Cefuroxime Sodium 1.50 gm Inj 1 Vial Cefoprim 250 mg Tab Cefuroxime Axetil 250 mg Tab 1x4 Cefoprim 500 mg Tab Cefuroxime Axetil 500 mg Tab 1x4 Clavox 1200 mg Inj Amoxycillin &Clavulanate 1 gm+200 mg 1 Vial Forzid 1 gm Ceftazidime 1 gm 1 Vial Forzid 2 gm Ceftazidime 2 gm 1 Vial Gavir 250 mg Cap Ganciclovir 250 mg 1x8 Tab Gavir 500 mg Inj Ganciclovir 500 mg Inj 1 Vial Iminem 200 mg Inj Imipenem 250 mg& Cilastatin 250 mg 1 Vial Iminem 500 mg Inj Imipenem 500 mg& Cilastatin 500 mg 1 Vial Kephazone 1 gm Inj Cefoperazone Sodium 1 gm 1 Vial Kephazone S 1 gm Inj Sulbactam/Cefoperazone Sodium 1 gm 1 Vial Kephazone S 2 gm Inj Sulbactam/Cefoperazone Sodium 2 gm 1 Vial Linzid 600 mg Tab Linezolid 600 mg 1x4 Tab Menem 1 gm Inj Meropenem 1 gm Inj 1 Vial Menem 500mg Inj Meropenem 500mg Inj 1 Vial Mucosys 20 % 2 ml Sterile Acetylcysteine 20 % Solution 1 Amp of 2 ml Mucosys 20 % 5 ml Sterile Acetylcysteine 20 % Solution 1 Amp of 5 ml Netmicin 100 mg Inj Netlimicin Sulphate U.S.P 100 mg 1 Amp Netmicin 200 mg Inj Netlimicin Sulphate U.S.P 200 mg 1 Amp Netmicin 300 mg Inj Netlimicin Sulphate U.S.P 300 mg 1 Amp Netmicin 500 mg Inj Netlimicin Sulphate U.S.P 500 mg 1 Amp Noralin Inj Sterile Noradrenline Concentrate I.P. 1 Amp Sol-U-Pred 1000 mg Inj Methyl Prednisolone Sodium Succinate 1 Vial Sol-U-Pred 500 mg Inj Methyl Prednisolone Sodium Succinate 1 Vial Tazin 2.25 gm Inj Piperacillin/Tazobactam 2.25 gm Inj 1 Vial Tazin 4.5 gm Inj Piperacillin/Tazobactam 2.25 gm Inj 1 Vial Tecoplan 200 mg Teicoplanin 200 mg 1 Vial Tecoplan 400 mg Teicoplanin 400 mg 1 Vial Ticamic 3.1 gm Inj Ticarcillin 3 gm & Clavulanic Acid 100 mg Inj 1 Vial Tocin 80 mg I.M./I.V Tobramycin Sulphate 80 mg/2 ml 1 Vial Unicalcin 100 i.u Inj Synthetic Salmon Calcitonin 100 i.u 1 Amp Unicalcin 50 i.u Inj Synthetic Salmon Calcitonin 50 i.u 1 Amp Uniclor 125 mg Disp Tab Cefaclor 125 mgtab 1x6 Tab Uniclor 250 mg Disp Tab Cefaclor 250 mg Tab 1x6 Tab Uniclor 375 mg MR Tab Cefaclor 375 mg Tab 1x6 Tab Uniclor 500 mg Cap Cefaclor 500 mg Cap 1x8 Cap Uniclor 750 mg MR Tab Cefaclor 750 mg Tab 1x6 Tab
5 Unirab 200 mg Rabeprazole Sodium 20 mg 1 Vial Unitrax S 1.5 gm Ceftiaxone/Sulbactam 1.5 gm 1 Vial Univir Inj Acyclovir 250 mg Inj 1 Vial Vancotech CP 500 mg Inj Vancomycin Hydrochloride 500 mg 1 Vial Troikaa Parenterals Brand Name Generic Name Strength PREMIUM ANAESTHETIC RANGE Benzosed Inj. Midazolam HCL 1mg,5mg, Bupitroy Inj. Bupivacaine HCL 0.25%.0.50%,Heavy, Droperol Inj. Droperidol 2.5mg/1ml, Isotroy isoflurane Usp 100ml,200ml, Troycurium Inj. Atracurium 2.5ml,5ml, Augumax 1.2 Inj PREMIUM ANTIBIOTIC RANGE Amoxicillin 1 gm + Clavulanic Acid 200 mg Fortacef Inj. Ceftazidime 250mg,500mg,1gm, Mikaject Inj. Amikacin Sulphate 250/2ml,500/2ml, Tromycetin Inj. Chloramphenicol Sodium Succinate 1gm, Troyaxone Inj. ceftiaxone 1gm, Troycef Inj. Cefotaxime Sodium 250mg, 1gm, Troypenem Inj Meropenem 500 mg/1 gm Troypipera -T Inj. Piperacillin 4g +Tazobactum 0.5g 4.5g, Cardiplegin Inj. CRITICAL CARE PARENTERALS steril Consentrate Cardioplegia Infusion Dobucin Inj Dobutamine 50mg/ml Dopacin Inj. Dopamine HCL 40mg, Eurythmic Inj. Amiodarone HCL EurythmicTab. Amiodarone HCL Myonit Inj Nitroglycerin Inj 25 mg & 50 mg Natricarb Inj. Sodium Bicarbionate 7.5%w/v 25ml, Pruside Inj. Sodium Nitroprusside I.V 50mg, Tachyban Inj. Adenosine 3mg/ml,
6 Karle Health Sciences Private Ltd Karbicin Inj Pegylated Liposomal Doxorubicin Hcl 20 mg 1 VIAL Kocetaxel 120 mg Inj Docetaxel 120 mg 1 VIAL Kocetaxel 80 mg Inj Docetaxel 80 mg 1 VIAL Kocetaxel 20 mg Inj Docetaxel 20 mg 1 VIAL Kemcitabine 1.4 gm Inj Gemcitabine 1.4 gm 1 VIAL Kemcitabine 1 gm Inj Gemcitabine 1 gm 1 VIAL Kemcitabine 200mg Inj Gemcitabine 200 mg 1 VIAL Imalate 100 mg Tab Tab Imatinib 100 mg 1x10 Imalate 400 mg Tab Tab Imatinib 400 mg 1x10 Karlitaxel 30 mg Inj Paclitaxel 30 mg 1 VIAL Karlitaxel 100 mg Inj Paclitaxel 100 mg 1 VIAL Karlitaxel 260 mg Inj Paclitaxel 260mg 1 VIAL Kemozolomide 100 mg Cap Temozolamide 100 mg 1x5 Cap Kemozolomide 250 mg Cap Temozolamide 250 mg 1x5 Cap Kefitinib 250 mg Tab Tab Gefitinib 250 mg 1x10 Tab Letrogold 2.5 mg Tab Tab Letrozole 2.5 mg 1x10 Tab Kanstrozole 1 mg Tab Tab Anastrazole 1mg 1x10 Tab Kapecitabine 500 mg Capecitabine 500 mg 1x10 Cap Karfil 300 mcg Inj Filgrastim 300 mcg PFS Kanisetron 1 mg/ml Inj Granisetron 1 mg/ml 1 VIAL Kimacin Inj Imipenem500 mg +Cilastatin 500 mg 1 VIAL Kimacin Inj Imipenem250 mg +Cilastatin 250 mg 1 VIAL
7 CumbalaHill Life Sciences Private Limited ANTI CANCER Epirubihill 10 mg Inj Epirubicin 10 mg 1 Vial Epirubihill 50 mg Inj Epirubicin 50 mg 1 Vial Paclihill 30mg Inj Paclitaxel 30 mg 1 Vial Paclihill 100mg Inj Paclitaxel 100 mg 1 Vial Paclihill 260mg Inj Paclitaxel260 mg 1 Vial Docehill 20 mg Inj Docetaxel 20 mg 1Vial Docehill 80 mg Inj Docetaxel 80 mg 1Vial Palonohill 0.25mg Palenosetron Hcl 0.25mg 1 Vial Bleohill 15 units Bleomucin 15 units 1 Vial Melphahill 2mg Melphalan 2 mg 25 Tab Melphahill 5mg Melphalan 5 mg 25 Tab Granohill 300mcg Inj Filgrastim 300 mcg PFS Piptazohill Piperacillin + Tazobactum 4.5 mg 1 Vial Gefihill Tab Tab Gefetinib 250 mg 1x10 Tab Temozohill 20 mg Cap Cap Temozolomide 20 mg 5 Cap Temozohill 100 mg Cap Cap Temozolomide 100 mg 5 Cap Temozohill 250 mg Cap Cap Temozolomide 250 mg 5 Cap Varifarma Laboratories Brand Name Generic Name Strength Varigestrol 160 mg Tab Tab Megestrol Acetate 160 mg 1x10 Tab DE ADDICTION Chronol Tab Disulfiram Tab 1x4 Tab Amronco Brand Name Generic Name Strength Xero Sugar free buffered Sorbitol Tablets 300mg Amrad Cream Cream for Radiation Induced Dermatitis 50g WFS - Powder Waste Fluid Solidifier 40g
8 Shantha Biotech Brand Name Generic Name Strength Shanvac B Hepatitis B 0.5/1/10 mi Shantyph Typhoid Vaccine 0.5/2.5 ml Shan -5 Hepatitis+Hib+DPT 0.5 ml Shanthib DPT Hib +DPT 0.5 ml Shanthib Liq Hib Vaccine Shanthib Lyophilised Hib Vaccine Lyophilised Shan T.T Tetanus Inj 0.5/10/20 ml Authorised Distributors for Miracalus Pharma Pvt Ltd Gold Shield Health Care Limited United Biotech Pvt Ltd Troikaa Pharmaceuticals Karle Health Sciences Pvt Ltd Cumbala Hill Life Sciences Varifarma Laboratories Amronco Shantha Biotech
Rajasthan Medical Services Corporation Limited, Jaipur
Rajasthan Medical Services Corporation Limited, Jaipur List of Drugs- Purchase order placed to successful Bidders Tendered on 05/07/2011 S.No. Name of Drug 1 Atropine Sulphate Injection 0.6 mg /ml (SC/IM/IV
More informationVMG Pharmaceuticals Pvt. Ltd.
S. No. Product Name S trength Dos age form Oncology 1 A nastrazole 1 mg Tablets 2 Bicalutamide 50 mg Tablets 3 Bleomycin 15units,30units Injection 4 Bortezomib 3.5 mg Injection 5 Capecitabine 500 mg Tablets
More informationCOST CONSIDERATIONS Union for International Cancer Control 2014 Review of Cancer Medicines on the WHO List of Essential Medicines!!!!!!!!!
UICCEMLCostingScenarios BackoftheEnvelope Calculations PreparedforWorkingGroupSession:19621November2014,Geneva MethodsSummary We have chosen a conservative approach, calculating cost per vial. We have
More informationLIST OF DRUGS / MEDICINES ITEMS FOR THE YEAR (Non-Prequalified Items) A: Injection Antimicrobials Sr. No.
LIST OF DRUGS / MEDICINES ITEMS FOR THE YEAR 2017-2018 (Non-Prequalified Items) A: Injection Antimicrobials Sr. 1 Amphotericin B vial of 50mg with wfi individually packed in carton with 2 Artemether 80mg/ml
More informationDry injection list 1-Ceftriaxone 1000 mg & Sulbactam 500 mg Inj. 2-Ceftriaxone 500 mg & Sulbactam 250 mg Inj.
Dry injection list 1-Ceftriaxone 1000 mg & Sulbactam 500 mg Inj. 2-Ceftriaxone 500 mg & Sulbactam 250 mg Inj. 3-Ceftriaxone 250mg & Sulbactam 125mg Inj. 4-Ceftriaxone 125mg & Sulbactam 62.5mg Inj. 5-Rabeprazole
More informationExhibit B United States Patent Application 20020012663 Kind Code A1 Waksal, Harlan W. January 31, 2002 Treatment of refractory human tumors with epidermal growth factor receptor antagonists Abstract A
More informationWest of Scotland Cancer Network Guideline for Managing Chemotherapy Induced Nausea and Vomiting
West of Scotland Cancer Network Guideline for Managing Chemotherapy Induced Nausea and Vomiting Definitions Acute nausea and vomiting Delayed nausea and vomiting Anticipatory nausea and vomiting Initial
More informationObjective: To provide a standard procedure for the recycling of unused medication and the disposal of medicines across all BCPFT Hospital sites.
WARDS/DEPARTMENTS By: 0 01/09/019 1 of 3 Objective: To provide a standard procedure for the recycling of unused medication and the disposal of medicines across all BCPFT Hospital sites. Scope: All Black
More informationGUIDELINES FOR ANTIEMETIC USE IN ONCOLOGY SUMMARY CLASSIFICATION
GUIDELINES FOR ANTIEMETIC USE IN ONCOLOGY SUMMARY More than half of all cancer patients experience nausea or vomiting during the course of their treatment. If nausea or vomiting becomes severe enough,
More informationJ1556 INJECTION, IMMUNE GLOBULIN (BIVIGAM) 500 MG $ J1559 INJECTION, IMMUNE GLOBULIN (HIZENTRA) 100 MG $14.364
G0333 INITIAL 30-DAY SUPPLY AS A BENEFICIARY $57.000 J0133 INJECTION, ACYCLOVIR 5 MG $0.470 J0285 INJECTION, AMPHOTERICIN B 50 MG $10.280 J0287 INJECTION, AMPHOTERICIN B LIPID COMPLEX 10 MG $21.850 J0288
More informationApproved L1 rates and tenderers for 162 Speciality drugs for the year
Approved L1 rates and tenderers for 162 Speciality drugs for the year 2011-2012 Sl. Name of the 1 G3 2 G6 3 G8 Aceclofenac Tab. - Acyclovir Inj., USP - Adefovir Dipivoxil Tab. - 10mg 10 X 10 4899800 Vial
More informationProduct Name Strength Dosage Form Therapeutic Area Dossier Status. Aceclofenac 100mg Film coated Tablets Analgesia-inflammation Approved
Product Name Strength Dosage Form Therapeutic Area Dossier Status Aceclofenac 100mg Film coated Tablets Analgesia-inflammation Approved Alendronate Sodium 10/70mg Tablets Osteoporosis Approved Anastrozole
More informationProvisional L1 rate of Non SSI and SSI tenderers for the Speciality drugs for the year
Provisional L1 rate of Non SSI and SSI tenderers for the Speciality drugs for the year 2011-12 Sl. 1 G3 Aceclofenac Tab. - 100mg 10 X 10 16.71 Salus Pharmaceuticals 17.91 Rikenbik Pharma (SSI tenderer)
More informationICON Formulary - October 2018 Legend - ICON Protocols Essential (previously Standard), Core, Enhanced Core, Enhanced Enhanced
ICON Formulary - October 2018 Legend - ICON Protocols Essential (previously Standard), Core, Enhanced Core, Enhanced Enhanced Class Medicine Name Nappi Strength Form Size Route Abiraterone Acetate ZYTIGA
More informationMASCC Guidelines for Antiemetic control: An update
MASCC / ISOO 17 th International Symposium Supportive Care in Cancer June 30 July 2, 2005 / Geneva, Switzerland MASCC Guidelines for Antiemetic control: An update Sussanne Börjeson, RN, PhD Linköping University,
More informationNIT 97 - APPROVED DRUG LIST
1 EDL0422 Name of the and Strength Chlorine based compound NADCC Tablets 75 mg With Available Chloroine 45 mg BIS* 1 pack of 1000 tablets VAT 440748 71.0000 74.5500 ADHISH INDUSTRIES 2 120092 Cloxacillin
More informationWHO Model List (revised April 2002)
Essential Medicines Explanatory Notes The complementary list presents essential medicines for priority diseases which are efficacious, safe and cost-effective but not necessarily affordable, or for which
More informationDrug Name. Code Artesunate Injection 60 mg/ml Chloroquine Phosphate Injection 40 mg/ml
Sr.No New Drug Code Drug Name 1 26.1.275.2 Artesunate Injection 60 mg/ml 2 26.1.277.2 Chloroquine Phosphate Injection 40 mg/ml 3 26.1.277.4 Chloroquine Phosphate Tablet 250 mg, equivalent to 155 mg chloroquine
More informationTABLETS & CAPSULES. 8 Artemether + Lumafentarine Tablet (24 Tablet ) and Candesartan Tablet 8mg,16mg and 32 mg
TABLETS & CAPSULES Sr. No. Name of the product Strength 1 6-Mercaptopurine Tablets 50mg 2 Acetazolamide Tablet 250 mg 3 Al2O3 + Mg(OH)2 chewable Tablet 200 mg/200 mg 4 Allopurinol Tablet 100 mg 5 Ambroxol
More informationANTI COLD / ANTI ALLERGIC / ANTI-ASTHMATICS GIT PRODUCTS
SR. NO 1 ANTI COLD / ANTI ALLERGIC / ANTI-ASTHMATICS Paracetamol 500 mg, Phenylephrine HCL 5 mg With Chlorpheniramine Maleate 2 mg & Caffeine 30 mg Tablets 2 Salbutamol Tablets BP 2 mg 3 Salbutamol Tablets
More informationRelease of the 2017/18 Invitation to Tender
2 November 2017 Release of the 2017/18 Invitation to Tender The 2017/18 Invitation to Tender (2017/18 ITT) has been distributed today. If you have already registered your e-mail address with PHARMAC s
More informationGuidelines on Chemotherapy-induced Nausea and Vomiting in Pediatric Cancer Patients
Guidelines on Chemotherapy-induced Nausea Vomiting in Pediatric Cancer Patients COG Supportive Care Endorsed Guidelines Click here to see all the COG Supportive Care Endorsed Guidelines. DISCLAIMER For
More informationLIST OF PRODUCTS INJECTIONS DRY POWDER INJECTIONS & LIQUID INJECTIONS. Therapeutic Segment. S.No Name Form Pharmacope
LIST OF PRODUCTS S.No Name Form Pharmacope ia Strength Therapeutic Segment ECTIONS DRY POWDER ECTIONS & LIQUID ECTIONS 1 a b Arteether 75mg/ml 150 mg/2ml & 225 mg/3ml 2 Amikacin Sulfate IP/ 100/250/500
More informationASSESSMENT OF THE PAEDIATRIC NEEDS CHEMOTHERAPY PRODUCTS (PART I) DISCLAIMER
European Medicines Agency Evaluation of Medicines for Human Use London, September 2006 Doc. Ref.: EMEA/384641/2006 ASSESSMENT OF THE PAEDIATRIC NEEDS CHEMOTHERAPY PRODUCTS (PART I) DISCLAIMER The Paediatric
More informationDME MAC Jurisdiction C Drug Fees, Pharmacy Dispensing Fees and Pharmacy Supply Fees Effective 01/01/2018 through 03/31/2018
G0333 PHARMACY DISPENSING FEE FOR INHALATION DRUG(S); INITIAL 30-DAY SUPPLY AS A BENEFICIARY $57.000 J0133 INJECTION, ACYCLOVIR 5 MG $0.068 J0285 INJECTION, AMPHOTERICIN B 50 MG $32.987 J0287 INJECTION,
More informationEmetogenicity level 1. Emetogenicity level 2
Emetogenicity level 1 15 mins Pre-Chemo Maxalon 10mg po During chemo and Post Chemo 3 days Maxalon10mg po 8 hourly Increase Maxalon 20mg po 8 hourly Change to Cyclizine 50mg po 8 hourly 3 days If nausea
More informationUse of Prophylactic Growth Factors and Antimicrobials in Elderly Patients with Cancer: A
Supportive Care in Cancer Use of Prophylactic Growth Factors and Antimicrobials in Elderly Patients with Cancer: A Systematic Review of the Medicare Database Romina Sosa, Shuling Li, Julia T. Molony, Jiannong
More informationDME MAC Jurisdiction B Drug Fees, Pharmacy Dispensing Fees and Pharmacy Supply Fees Effective 01/01/2019 through 03/31/2019
G0333 PHARMACY DISPENSING FEE FOR INHALATION DRUG(S); INITIAL 30-DAY SUPPLY AS A BENEFICIARY $57.000 J0133 INJECTION, ACYCLOVIR 5 MG $0.048 J0285 INJECTION, AMPHOTERICIN B 50 MG $31.668 J0287 INJECTION,
More informationOFFERâ S INJECTABLES
A B Page 6 7 8 9 0 C 6 7 Page 8 9 0 D E Page 6 7 8 9 F Page 6 7 8 9 G H Page 6 7 8 9 I 6 7 Page 6 8 9 0 J 6 7 Page 7 K 6 7 8 9 L Page 8 6 7 8 9 0 Page 9 6 7 8 9 0 Page 0 OFFERâ S INJECTABLES Alimentary
More informationELECTRONIC HEALTH RECORD (EHR) ENHANCEMENTS FOR MARCH 15, 2016 SUMMARY
ELECTRONIC HEALTH RECORD (EHR) ENHANCEMENTS FOR MARCH 15, 2016 SUMMARY Problem Opening PACS Images on ipads or ibooks has Been Fixed Changes have been made in PROD to enable user credentials to be passed
More information1 17 ACITRETIN 10MG CAP 20, ,000 14,000 4, ACITRETIN 25MG CAP 50, ,000 35,000 10,000
ردیف کد ژنریک نام ژنریک مبلغ پوشش وزارت بهداشت مبلغ پوشش بیمه مبلغ پرداخت بیمار درصد پرداخت بیمار قیمت اعالمی وزارت بهداشت نام تجاری 1 17 ACITRETIN 10MG CAP 20,000 10.0 2,000 14,000 4,000 2 18 ACITRETIN
More informationProduct Visual Guide
Product Visual Guide Teamwork A team with an unflinching faith in one another is one of our core strength. Excellence Achieving excellence is not the end result, we begin with excelling in any endeavor.
More informationProtocol Number Tumour Group Protocol Name on NCCP website 22/02/ Lung Afatinib Monotherapy 244 Gastrointestinal Regorafenib Monotherapy
Last Updated 22-Feb-18 Date of last update Protocol Number Tumour Group Protocol Name on NCCP website 22/02/2018 221 Afatinib Monotherapy 244 Gastrointestinal Regorafenib Monotherapy 249 Gynaecology Intrathecal
More informationRelease of the 2014/15 Invitation to Tender
6 November 2014 Release of the 2014/15 Invitation to Tender The 2014/15 Invitation to Tender (2014/15 ITT) has been distributed today. Please note that the Electronic Portal will not be available until
More informationSCI. SickKids-Caribbean Initiative Enhancing Capacity for Care in Paediatric Cancer and Blood Disorders
1.0 Introduction The (SCI) is a not-for-profit collaboration between the Hospital for Sick Children (SickKids), Toronto, Canada, and seven Caribbean health care institutions across six countries that strive
More information1 ml) (100 x. 10 ml)
SCHEDULE COPY NICIPAL CORPORATION OF GREATER MUM NTRAL PURCHASE AUTHORITY DEPARTME SCHEDULE I OF 2010-2011 INJECTIONS & SERA VACCINES CONTRACT PERIOD : 1-1-2010 To 31-12-2011 Item Description Quantity
More information1 ( concentrated electrolytes ) ก
ก ก HAD 1 ( concentrated electrolytes ) ก ก ก ( ) ก ก ก ก 2 ก ก ก (Patient care unit) ก ก ก ก ( Hemodialysis ) ก ก ก ก ก ก stock card ก ก ( High Alert Drug (HAD)) ก ก ก ก (Pharmacy and Therapeutic Committee
More informationProtocol Number Intrathecal Methotrexate for CNS 01/02/2018 Prophylaxis in GTN Gynaecology 249
Last updated Feb 9, 2018 Revision due Protocol Name on NCCP website Tumour Group Protocol Number Intrathecal Methotrexate for CNS 01/02/2018 Prophylaxis in GTN Gynaecology 249 Two Day Etoposide CISplatin
More informationJob title: Consultant Pharmacist/Advanced Practice Pharmacist
Title : Guidelines for the Use of Antiemetics Purpose: To provide trust-wide guidance on the safe and effective use of antiemetics for the prevention and treatment of chemotherapy and radiotherapy induced
More informationMEDICAL NECESSITY GUIDELINE
PAGE: 1 of 10 IMPORTANT REMINDER This Clinical Policy has been developed by appropriately experienced and licensed health care professionals based on a thorough review and consideration of generally accepted
More informationCURRENT DRUG SHORTAGES (through February 22, 2013) CURRENT & ONGOING SHORTAGES CRITICAL SHORTAGES
CURRENT DRUG SHORTAGES (through February 22, 2013) CRITICAL SHORTAGES Acetylcysteine Inhalation Analgesic Buprenorphine Caffeine and Ergotamine Acyclovir Meperidine Injection Adenosine Amino Acid Products
More information1 The Cancer Programs Regulation (AR 242/98) is amended by this Regulation.
Alberta Regulation 18/2005 Cancer Programs Act AMENDMENT REGULATION Filed: February 22, 2005 For information only: Made by the Minister of Health and Wellness (M.O. 9/2005) on February 17, 2005 pursuant
More informationSubject: Palonosetron Hydrochloride (Aloxi )
09-J0000-87 Original Effective Date: 02/15/09 Reviewed: 07/09/14 Revised: 03/15/18 Subject: Palonosetron Hydrochloride (Aloxi ) THIS MEDICAL COVERAGE GUIDELINE IS NOT AN AUTHORIZATION, CERTIFICATION, EXPLANATION
More informationHaematology, Oncology and Palliative Care Directorate.
Anticancer Treatment for Administration on the Somerset Mobile Chemotherapy Unit The table below details the suitability of different types of anticancer treatment for administration on the Somerset Mobile
More informationGuidelines for the Use of Anti-Emetics with Chemotherapy
Guidelines for the Use of Anti-Emetics with The purpose of this document is to provide guidance on the rational use of anti-emetics for prevention and treatment of chemotherapy-induced nausea and vomiting
More informationAppendix 2. Adjuvant Regimens. AC doxorubin 60 mg/m 2 every 3 weeks x 4 cycles Cyclophosphamide 600 mg/m 2
Appendix 2 Adjuvant Regimens AC doxorubin 60 mg/m 2 every 3 weeks x 4 cycles Cyclophosphamide 600 mg/m 2 CMF IV cyclophosphamide 600 mg/m 2 days 1 & 8 every 4 weeks methotrexate 40 mg/m 2 for 6 cycles
More informationAdverse effects of anticancer drugs (Antimetabolites agents, Alkylating agents, Antimicrotubule agents, Miscellaneous agents, Immune therapies and
35 Adverse effects of anticancer drugs (Antimetabolites agents, Alkylating agents, Antimicrotubule agents, Miscellaneous agents, Immune therapies and Biologically directed therapies ) 1 1- Nausea and vomiting
More informationAn assessment of the price of oncology drugs in Ukraine 2015
An assessment of the price of oncology drugs in Ukraine 2015 Prashant Yadav University of Michigan October 2016 The views and opinions expressed in this report are those of the author and should not be
More informationCare With Commitment...
Care Commitment Knowledge Responsibility Respect Trust Care With Commitment... www.cbcpharma.com 01 About History Chandra Bhagat Pharma Pvt. Ltd. a well established Pharmaceutical Company founded by Mr.
More informationTENDER RESULTS. Notification of Product Changes (NOPC) forms and Pharmacodes
30 June 2014 TENDER RESULTS PHARMAC has resolved to award tenders for Sole Subsidised Supply Status and Hospital Supply Status for some products included in the 2012/13 Invitation to Tender, dated 31 October
More informationVasco OP Free Sterile Surgical and Protective Gloves
DATA SheeT EN 374:2003 EN 374:2003 AQl 0.65 B. Braun Melsungen AG confirms that Vasco OP Free gloves comply with the following standards and directives: ec certificates AnD APPlieD STAnDArDS Medical device
More informationFOR A HIGHER DEGREE OF CONFIDENCE
SELECTING THE RIGHT HAND PROTECTION WHEN WORKING WITH CHEMOTHERAPY DRUGS. > Introduction Manufacturing specialized products in a pharmaceutical manufacturing environment has a specific set of requirements
More informationThinking different. Spreading light.
Thinking different. Spreading light. Index INDEX Novel Drug Delivery s Aquatech Process Decompaction Technology Lipotech Process QPS Technology Matrix Technology Microsolve Technology Mucoadhesive Drug
More informationThe following are J Code requirements
The following are J Code requirements J Codes 20610 Arthrocentesis, aspiration and/or injection; major joint or bursa (eg, shoulder, hip, knee joint, subacromial bursa) A9579 Injection, gadolinium based
More informationUP Health System Marquette Medication Guideline High Alert Drugs
1 ALTEPLASE SOLR 100 MG ACTIVASE 305010 50242008527 TRUE ALTEPLASE SOLR 50 MG ACTIVASE 305008 50242004413 TRUE AMIODARONE INJ 50 MG/ML CORDARONE IV 305035 63323061609 TRUE AMIODARONE INJ 50 MG/ML CORDARONE
More informationAPPHON/ROPPHA Guideline for the Prevention and Management of Chemotherapy Induced Nausea and Vomiting in Children with Cancer
APPHON/ROPPHA Guideline for the Prevention and Management of Chemotherapy Induced Nausea and Vomiting in Children with Cancer 5850/5980 University Avenue, PO Box 9700, Halifax, N.S. B3K 6R8 PEDIATRIC HEMATOLOGY/ONCOLOGY
More informationGuideline for Classification of the Acute Emetogenic Potential of Antineoplastic Medication in Pediatric Cancer Patients
Guideline for Classification of the Acute Emetogenic Potential of Antineoplastic Medication in Pediatric Cancer Patients POGO Antineoplastic Induced Nausea and Vomiting Guideline Development Panel: L.
More informationChapter 5 ~ Infections
Chapter 5 ~ Infections: Special Section 1 of 6 Chapter 5 ~ Infections Please refer to The Hillingdon Hospitals NHS Trust Antibiotic Guidelines, Policy number 233, and Surgical Prophylaxis Policy, Policy
More informationVasco OP Underglove Sterile Surgical and Protective Gloves
data sheet EN 374:2003 EN 374:2003 AQL 0.65 B. Braun Melsungen AG confirms that Vasco OP Underglove gloves comply with the following standards and directives: EC CERTIFICATES AND Applied standards Medical
More informationSELECTING THE RIGHT HAND PROTECTION WHEN WORKING WITH CHEMOTHERAPY DRUGS
SELECTING THE RIGHT HAND PROTECTION WHEN WORKING WITH CHEMOTHERAPY DRUGS SELECTING THE RIGHT HAND PROTECTION WHEN WORKING WITH CHEMOTHERAPY DRUGS Manufacturing specialized products in a pharmaceutical
More informationDRUGS YOU NEED TO KNOW
jfitzake@d.umn.edu Page 1 of 7 DRUGS YOU NEED TO KNOW ALKYLATING AGENTS (blue cards) BUSULFAN CARMUSTINE (BCNU) CYCLOPHOSPHAMIDE DACARBAZINE LOMUSTINE (CCNU) MECHLORETHAMINE MELPHALAN THIOTEPA NATURAL
More informationPrimary malignant neoplasms, not lymphatic or hematopoietic. Secondary malignant neoplasms (i.e.metastatic) Malignant neoplasm, unknown site
Supplementary Table 1. ICD-9-CM codes used to define cancer ICD-9 Diagnosis code 140.xx-172.xx 174.xx-195.xx 196.xx 198.xx 199.xx 200.xx-208.xx Description Primary malignant neoplasms, not lymphatic or
More informationWhat s New
What s New 23.12.2016 NPPA has fixed/revised ceiling prices of 55 scheduled formulations of Schedule-I under Drugs ( Control) Amendment Order,2016 and Retail of 29 formulations under DPCO, 2013 in related
More informationVasco OP Sensitive Sterile Surgical and Protective Gloves
data sheet EN 374:2003 EN 374:2003 AQL 0.65 B. Braun Melsungen AG confirms that Vasco OP Sensitive gloves comply with the following standards and directives: EC CERTIFICATES AND Applied standards Medical
More informationDRUG PROPERTIES YOU NEED TO KNOW
Dr. Janet Fitzakerley Summer 2013 Med 6541 Hematopoiesis and Host Defences jfitzake@d.umn.edu www.d.umn.edu/~jfitzake Page 1 of 11 DRUG PROPERTIES YOU NEED TO KNOW 1. Mechanism of action a. chemical class
More informationDRUG PROPERTIES YOU NEED TO KNOW
jfitzake@d.umn.edu www.d.umn.edu/~jfitzake Page 1 of 8 DRUG PROPERTIES YOU NEED TO KNOW 1. Mechanism of action a. chemical class b. resistance 2. Pharmacokinetics 3. Therapeutic uses 4. Major side effects/toxicities
More informationPatient 1: Patient 2:
Appendix A Compiled by Dr. Raymond Ngeh and Dr. Robert Luk Clinical notes and PET/CT scan images of eleven patients: 1. Middle age woman has cancer of the pancreas in the body of the gland. After just
More informationThe AngCN Antiemetic Guidelines
The AngCN Antiemetic Guidelines Guidelines for the Management of Nausea and Vomiting in Adult Patients Receiving Chemotherapy and/or Radiotherapy AngCN Document Reference: AngCN-CCG-C31 CONTENTS 1.0 Introduction
More informationMedication Review. Cancer Chemotherapy Drugs. Pharmacy Technician Training Systems Passassured, LLC
Medication Review Cancer Chemotherapy Drugs Pharmacy Technician Training Systems Passassured, LLC Medication Review, Cancer Chemotherapy Drugs PassAssured's Pharmacy Technician Training Program Medication
More informationSubject: Fosnetupitant-Palonosetron (Akynzeo) IV
09-J3000-01 Original Effective Date: 06/15/18 Reviewed: 05/09/18 Revised: 01/01/19 Subject: Fosnetupitant-Palonosetron (Akynzeo) IV THIS MEDICAL COVERAGE GUIDELINE IS NOT AN AUTHORIZATION, CERTIFICATION,
More informationAn introduction to the Essential Medicines concept: balancing innovation with public health priorities
An introduction to the Essential Medicines concept: balancing innovation with public health priorities WHO HQ, Geneva 11 October 2017 Nicola Magrini Secretary, WHO Expert Committee on the Selection and
More informationGuideline Update on Antiemetics
Guideline Update on Antiemetics Clinical Practice Guideline Special Announcements Please check www.asco.org/guidelines/antiemetics for current FDA alert(s) and safety announcement(s) on antiemetics 2 Introduction
More informationClinical Tools and Resources for Self-Study and Patient Education
Clinical Tools and Resources for Self-Study and Patient Education CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING CLINICIAN'S RESOURCE GUIDE The clinical tools and resources contained herein are provided as educational
More informationElite Pharma (Pvt.) Ltd., Lahore Pakistan (Injectables)
1 022237 Aqua Elite Water for Injection 5ml 100 x 5ml 2 022238 Neuro -S (Each 3ml contains: B1 + B6 + B12) Vitamins 25 x 3ml 5 x 3ml 100 x 3ml 4 024864 Elusen (Frusemide --- 20mg / 2ml] Diuretic 50 x 2ml
More informationPrevention and Management of chemo-and radiotherapy-induced nausea and vomiting
Prevention and Management of chemo-and radiotherapy-induced nausea and vomiting Focusing on the updated MASCC/ESMO guidelines Karin Jordan Department of Hematology and Oncology, University of Heidelberg
More informationDOXOrubicin, Cyclophosphamide (AC 60/600) 21 day followed by weekly PACLitaxel (80) Therapy (AC-T) 261 CARBOplatin (AUC4-6) Monotherapy-21 days
Last updated Oct 17, 2018 Tumour Group Protocol Number Protocol Name on NCCP website Breast 200 Trastuzumab (IV) Monotherapy 21 days 201 Trastuzumab (IV) Monotherapy 7 days 202 DOCEtaxel Monotherapy 100mg/m2
More informationOVERVIEW OF COMMENTS RECEIVED ON LIST OF PAEDIATRIC NEEDS ONCOLOGY I (CYTOTOXIC THERAPY)
European Medicines Agency Evaluation of Medicines for Human Use London, September 2006 Doc. Ref. OVERVIEW OF COMMENTS RECEIVED ON LIST OF PAEDIATRIC NEEDS ONCOLOGY I (CYTOTOXIC THERAPY) Table 1: Organisations
More informationApproved by TAC Order to be given within 1 month-date
Approved by TAC Order to be given within 1 month-date 01.10.2018 Sr.No 1 TAB DICLOFENAC 50 MG 2 CEFOTAXIM 500 INJET 3 Inj. Ceftriaxone 500mg Vial 4 Promethazine Inj.25 mg/ml 2 ml Amp 5 Inj. Diclofenac
More informationANCARD (CARDIOVASCULAR) SR. NO. PRODUCT DRUG NAME STRENGTH PACKING
ANCARD (CARDIOVASCULAR) SR. NO. PRODUCT DRUG NAME STRENGTH PACKING 1 ADENOSINE INJECTION CARNOSIN 6MG/2ML 1X2ML 2 AMINOCAPROIC ACID INJECTION HAMOSTAT 5 GM/20ML 1X20ML 3 AMIODARONE HCL INJECTION DURON
More informationRelease of the 2013/14 Invitation to Tender
07 November 2013 Release of the 2013/14 Invitation to Tender The 2013/14 Invitation to Tender (2013/14 ITT) has been distributed today via the electronic tender (etender) system. If you do not receive
More informationCHEMOTHERAPY/ ANTICANCER DRUGS/ NEOPLASTIC AGENTS
CHEMOTHERAPY/ 1 Oncology, Misc, Vaccines ANTICANCER DRUGS/ NEOPLASTIC AGENTS Important Terms: Cancer: A group of diseases involving abnormal cell growth with the potential to invade or spread to other
More informationFrom the joint NHS pharmacy technical services groups, for distribution via local NHS network groups:- Dear NHS Colleague,
From the joint NHS pharmacy technical services groups, for distribution via local NHS network groups:- Dear NHS Colleague, Supporting document for NPSA Injectables Patient Safety Alert Attached is a document
More informationTable updated 15 th February Sodium valporate 15 th February Ramipril & Felodipine 15 th February 2019
This table contains information on shortages of human medicines notified to the Health Products Regulatory Authority that have been resolved in the last 6 months. Table updated 15 th February 2019 Product
More informationTable III: 2019 Medicare Drug Fee Schedule* CY st Quarter Average Sales Price (ASP) Data Plus 6 Percent
Table III: 2019 Medicare Drug Fee Schedule* CY 2019 1st Quarter Average Sales Price (ASP) Data Plus 6 Percent *The Medicare payments allowance limits are effective Jan. 1 thru March. 31, 2019. CY 2019
More informationNo. Description Packing UOM
Republic of the Philippines PITC Pharma, Inc. Bids and Awards Committee INVITATION TO BID VARIOUS GENERIC & ONCOLOGY MEDICINES, MEDICAL DEVICE & SUPPLIES (PROJECT REF. NO. BAC/GOODS 2016-02-002) The PITC
More informationDRUG EXTRAVASATION. Vesicants. Irritants
DRUG EXTRAVASATION Vesicants Irritants Vesicants Antineoplastic drugs Amsacrine Dactinomycin Daunorubicin Docetaxel (rare) Doxorubicin Epirubicin Idarubicin Mechlorethamine Mitomycin Oxaliplatin (rare)
More informationProvisional L1 rate of Non SSI and SSI tenderers for the Veterinary drugs for the year
Provisional L1 rate of and tenderers for the Veterinary drugs for the year 2011-12 Sl. Name of the 1 A3 Rabies Veterinary Vaccine Inactivated I.P. Single Dose with Syringe 25.87 Brilliant Biopharma 2 D4
More informationNIT165 - RECEIVED PRICE DETAIL. Quantity in Unit/SKU. Company Name. Abbott Healthcare Private Ltd.
S C I Total 1 120003 Acenocoumarol/Nicoumalone Tablet 2 mg 10 x 10 15,000 223.33 6 6 26.7996 250.1296 2 120016 Amitriptyle Tab. IP - 25 mg 10X10 4,120 Micron Pharmaceuticals 27.9 12 3.348 31.248 3 120030
More informationSystemic Anti-cancer Therapy Care Pathway Guidelines for the management of SACT induced nausea and vomiting in adult patients
Systemic Anti-cancer Therapy Care Pathway Guidelines for the management of SACT induced nausea and vomiting in adult patients Pathway of Care Kent & Medway Cancer Collaborative Publication date June 2018
More informationPRE FILLED SYRINGES PRODUCTS
ONCOLOGY PRODUCTS 1 AMIFOSTINE FOR INJECTION 500 MG 1 VIAL 2 ANASTRAZOLE TABLETS 1 MG 1 X 10 BLISTER 3 BENDAMUSTIN HCL FOR INJECTION 25 / 100 MG 1 VIAL 4 BICALTUAMIDE TABLETS 50 MG 28'S BTL 5 BLEOMYCIN
More informationCytostatics Definition, Terminology
Dept. of Pharmacology, Faculty of Medicine, Masaryk University in Brno Cytostatics Notes for Pharmacology II Practicals This study material is exclusively for students of general medicine and dentistry
More informationRegimens highlighted in red contain an expensive drug that is not currently publicly funded for the regimen and treatment intent.
Palliative Breast Cancer Regimens The following table lists the evidence-informed regimens (both IV and non-iv) for breast cancer used in the palliative setting. It is expected that the prescribing oncologist
More informationDrug Name Tier Drug Name Tier
Drug Name Tier Drug Name Tier ABELCET 100 MG/20 ML VIAL 4 ACETYLCYSTEINE 10% VIAL 2 ACETYLCYSTEINE 20% VIAL 2 ACYCLOVIR 1,000 MG/20 ML VIAL 2 ACYCLOVIR 500 MG/10 ML VIAL 2 ADRUCIL 500 MG/10 ML VIAL 2 ALBUTEROL
More informationDrug Schedule For RC 145 ITEM S.No. NO. ITEM NAME and DESCRIPTION Unit Turnover (Rs.) EMD (Rs.)
HORMONES S.No. NO. NAME and DESCRIPTION Unit Turnover EMD NORETHISTERONE - Each tab to contain: 1 128 Norethisterone 5mg. 1 tab 5100000 50000 100000 DANAZOL TAB/CAP - Each tab/cap to contain: 2 132a Danazol
More informationCorporate Medical Policy
Antiemetic Injection Therapy Corporate Medical Policy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: antiemetic_injection_therapy 5/2015 3/2017 3/2018 3/2017 Description of Procedure
More informationAdult Intravenous Systemic Anticancer Therapy (SACT) Section A. SUMMARY of SCHEME QIPP Reference
CA2 Nationally standardised Dose banding for Adult Intravenous Anticancer Therapy (SACT) Scheme Name CA2: Nationally Standardised Dose Banding for Adult Intravenous Systemic Anticancer Therapy (SACT) Section
More informationCANCER PREVENTION AND ACCESS TO MEDICINES. Gracemarie Bricalli ESMO Head of International Affairs
CANCER PREVENTION AND ACCESS TO MEDICINES Gracemarie Bricalli ESMO Head of International Affairs ESMO s 2020 Vision: Access to cancer care ESMO s 2020 vision statement recognises that progress in the management
More informationWorking Formulary January 2013 Oncology Chemotherapy Regimens
Working Formulary January 2013 Oncology Chemotherapy Regimens In the currently changing commissioning landscape, this document is intended to represent the up to date list of non clinical trial chemotherapy
More informationLIST OF DRUGS THAT MAY BE COVERED UNDER YOUR MEDICAL BENEFIT
LIST OF DRUGS THAT MAY BE COVERED UNDER YOUR MEDICAL BENEFIT The following medications may be covered under your medical benefit if they are provided to you in your doctor s office or outpatient infusion
More information